Heart Disease Trial, Recruiting (NCT06308055)

Heart Disease Trial, Recruiting NCT06308055 Sponsor: Abiomed Inc. Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06308055 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are currently in intensive care or are planned to receive intensive care with a device called an Impella (a small heart pump) to support your heart.
You already have, or are planned to have, a way of measuring how well your heart is pumping blood (called cardiac output), such as a special heart catheter or an ultrasound of the heart (echocardiogram).

Who may not be able to join:

You are under 18 years of age.
You are pregnant.
It is expected that you will only need the Impella heart pump for less than 24 hours.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06308055

Sponsor: Abiomed Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

More information: https://clinicaltrials.gov/study/NCT06308055

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are currently in intensive care or are planned to receive intensive care with a device called an Impella (a small heart pump) to support your heart.
You already have, or are planned to have, a way of measuring how well your heart is pumping blood (called cardiac output), such as a special heart catheter or an ultrasound of the heart (echocardiogram).

Who may not be able to join:

You are under 18 years of age.
You are pregnant.
It is expected that you will only need the Impella heart pump for less than 24 hours.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Abiomed Inc.

Registry

ClinicalTrials.gov

Start date

4 October 2024

Est. completion

30 June 2027

Where this trial is recruiting

🇩🇪 Germany 🇮🇹 Italy 🇨🇭 Switzerland

Primary endpoints

Collection of hemodynamic parameters (Cardiac Output in l/min); Collection of hemodynamic parameters (Blood Pressure in mmHg, Pulmonary Artery Pressure in mmHg, Central Venous Pressure in mmHg, Pulmonary Capillary Wedge Pressure in mmHg); Collection of hemodynamic parameters (Mixed Venous Saturation in %); Collection of hemodynamic parameters (Pulmonary Vascular Resistance in In dynes/sec/cm-5 )

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov